Browsing Category
Top Industry News
7066 posts
BMS Completes $4.1-Bn Acquisition of Radiopharmaceutical Company RayzeBio
By
Bristol Myers Squibb (BMS) has completed its $4,1-billion acquisition of RayzeBio, a San Diego, California-based clinical-stage radiopharmaceutical company, The acquisition was announced in January 2024. RayzeBio has a position in…
AstraZeneca Completes $1.2-Bn Acquisition of Cell-Therapy Company Gracell
By
AstraZeneca has completed its acquisition of Gracell Biotechnologies, a Jiangsu, China-based clinical-stage bio/pharmaceutical company focused on cell-therapies, in a deal worth up to $1.2 billion ($1.0 billion upfront and $234…
AstraZeneca Completes $1.1-Bn Acquisition of Vaccine Company Icosavax
By
AstraZeneca has completed its acquisition of Icosavax, a Seattle, Washington-based clinical-stage vaccines company using a protein virus-like particle (VLP) platform, for $1.1 billion ($838 million at closing plus potential contingent…
Supplier News: Resilience, Jubilant HollisterStier & More
By
The latest from CDMOs, CMOs, and suppliers featuring National Resilience, Jubilant HollisterStier, Colorcon and Emergent BioSolutions. Biologics Manufacturing * Colorcon Ventures Invests in Vedanta Biosciences Formulation Development/Drug Product Manufacturing * Resilience Investing $225…